|View printer-friendly version|
|BrainStorm to Host Call Following President Trump's Citing of Company's ALS Treatment During "Right-to-Try" Bill Signing|
NEW YORK and PETACH TIKVAH, Israel,
To view President Trump's speech on C-SPAN (referencing ALS treatment in
"Since the signing of the 'Right-to-Try' bill, we have had numerous enquiries from patients, patient advocates and physicians who want to voice their opinions as we establish our RTT policy," stated Mr. Lebovits. "As part of our commitment to the community, we are happy to provide interested groups this opportunity to engage directly with us. We recognize the sense of urgency of ALS patients such as
Members of BrainStorm's senior management team, including
About BrainStorm Cell Therapeutics Inc.
View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-to-host-call-following-president-trumps-citing-of-companys-als-treatment-during-right-to-try-bill-signing-300658045.html